Skip to content

Clinical Study on Rapid Antioxidant Protection and Immune Modulating Effects.

Clinical Study on Rapid Antioxidant Protection and Immune Modulating Effects.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05042674
Enrollment
24
Registered
2021-09-13
Start date
2021-09-20
Completion date
2023-05-05
Last updated
2022-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pharmacokinetics

Brief summary

A trial on acute antioxidant protection and immune effects when 24 people consume a novel nutraceutical blend compared to a placebo on different test days.

Detailed description

A randomized, cross-over study design will be used to evaluate immune effects of consumption of 25 mg ergothioneine. On the first clinic day, participants will take a placebo with a one week wash out. Following the wash out week, participants will take 25 mg ergothioneine for 7 consecutive days.

Interventions

DIETARY_SUPPLEMENTPlacebo

after a blood draw placebo will be consumed followed by 2 additional blood draws

DIETARY_SUPPLEMENTErgothioneine, 25 miligrams

after a blood draw 25 miligrams of ergothioneine will be consumed followed be 2 additional blood draws

DIETARY_SUPPLEMENTErgothioneine, 25 miligrams, daily for 1 week

a blood draw will be administered after a week of consuming 25mg ergothioneine daily

Sponsors

Natural Immune Systems Inc
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Willing to comply with a 24-hour wash-out period for vitamins and nutritional supplements * Willing to maintain a consistent diet and lifestyle routine throughout the study * Willing to avoid consumption of meals where the predominant ingredients include mushrooms, seafood, and organ meat (liver, heart).\* * Willing to abstaining from exercising on the morning of a study visit * Willing to abstain from use of coffee, tea, and soft drinks for at least one hour prior to a clinic visit * Willing to abstain from music, candy, gum, computer/cell phone use, during clinic visits.

Exclusion criteria

* Previous major gastrointestinal surgery * Active chronic immunological disease * Currently taking daily OTC medications, prescription pain medications, antipsychotic medications, anti-inflammatory nutritional supplements judged by the study coordinator to negate or camouflage the effects if the test product, nutritional supplements containing medicinal mushroom extracts * Diagnose with Type I diabetes, autoimmune disorders * Getting regular joint injections * Active severe chronic disease (such as HIV, chronic hepatitis) * Currently experiencing intense stressful events/ life changes * Currently in intensive athletic training * Experiencing an unusual sleep routine * Unwilling to maintain a constant intake of supplements over the duration of the study * Anxiety about having blood drawn * Women who are pregnant, nursing, or trying to become pregnant * Known food allergies to ingredients in test product

Design outcomes

Primary

MeasureTime frameDescription
Change in level of reduced glutathione2 hoursMean fluorescence

Secondary

MeasureTime frameDescription
Change in mitochondrial mass and mitochondrial potential from baseline2 hoursMean fluorescence

Other

MeasureTime frameDescription
Change in mitochondrial mass and mitochondrial potential from baseline1 weekMean fluorescence
Change in level of reduced glutathione1 weekMean fluorescence

Countries

United States

Contacts

Primary ContactGitte Jensen, PhD
gitte@nislabs.com541-884-0112

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026